Completed NA INTERVENTIONAL 3-arm NCT01757340

Calorie Restriction With Leucine Supplementation

Calorie Restriction With Leucine Supplementation in Postmenopausal Women

Sponsor: Ajinomoto Co., Inc.

Conditions Menopause Obesity Osteoporosis Sarcopenia

Interventions Weight loss with normal protein and leucine intake Weight loss with protein/leucine supplementation

Updated 7 times since 2017 Last updated: Mar 24, 2017 Started: Sep 30, 2012 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Menopause and Obesity and is currently completed. Ajinomoto Co., Inc. leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Apr 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Apr 2017 [monthly]

Active Not Recruiting NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajinomoto Co., Inc.
Washington University School of Medicine

Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States